The full tender documents providing detailed information and application details are available to download from the drop-down menu below.

CEPI’s R&D team is responsible for the coordination of CEPI’s portfolio of vaccine candidates in preclinical and clinical stages of development.

To support this teams’ activities for COVID-19 vaccine development and beyond, along with the activities of the wider organisation, we are seeking the consultancy services from vaccine product development experts with experience in Vaccine Safety / pharmacovigilance and Clinical Vaccine Development.

CEPI coordinates the Research & Development & Manufacturing (RDM) Workstream within COVAX (the vaccine pillar under the Access to COVID-19 Tools-Accelerator, ACT-A). In developing candidate COVID-19 vaccines, CEPI actively supports a vaccine portfolio collaborating with IFPMA and DCVMN vaccine developers as well as many other firms, organisations and institutions.

Supporting individual vaccine programmes as well as strategic considerations related to pharmacovigilance strategies are key elements – in particular in a pandemic situation. Furthermore, it is important to connect pre-licensure and post-licensure activities related to vaccine safety and pharmacovigilance as part of the ecosystem. Lessons learnt from the COVID-19 pandemic will also serve to develop CEPI’s future strategic activities related to epidemic preparedness innovations.All work will be performed in compliance with CEPI’s clinical trials policy, standard procedures, regulations, and current ICH Good Clinical Practices guidelines.

How to Apply

For further information and details on how to apply, please download our full tender below.

Please apply by midnight, 8 January 2021.

If you have any questions, please contact Natalia Farhan: [email protected]

The full tender documents providing detailed information and application details are available to download from the drop-down menu below.

*****

Summary of Tender

CEPI is looking for consultancy support to assist with tender preparations for choosing a new IT provider.

The agreement with the current IT provider will reach its expiration date in January 2022. In line with CEPI’s procurement policies, recognising fair competition and transparency, we are planning to start working on a tender as soon as possible, preferably in December 2020. To allow for the potential migration of services to a new IT provider, we aim to sign a new contract no later than 1 October 2021.

With this objective in mind,  we are looking for consultancy support with experience in the following areas to assist CEPI in driving forward the procurement process for this tender from start to finish:

• Legal/Public Procurement experience
• Cybersecurity
• IT infrastructure and IT operations
• IT outsourcing
• Deep IT service provider knowledge

The supplier is expected to work over video meetings and physically meet in CEPI’s Oslo office when possible, given the current situation with the COVID-19 pandemic.

For further information and application details, please download the full tender documents from the drop-down menu below.

The deadline for submission is midnight (23:59:59 GMT) on Friday the 20^th November 2020. Proposals received after the deadline will not be considered. All proposals should be sent electronically, in PDF format, to [email protected].

Questions related to this request for proposal should be directed to: Maria Iacovone, CEPI Head of Operations at [email protected]

As a voluntary funded organisation, CEPI depends on the confidence of its donors to fulfil its mandate.

CEPI operates in a global environment and is exposed to continuously changing factors that can affect CEPI’s risk profile. CEPI’s due diligence process is an important tool to have an overview over such factors and enables CEPI to accurately evaluate and manage risks associated with its potential third parties and to provide reassurance to CEPI’s investors that funding is only awarded with prudent considerations.

Currently, CEPI has outsourced the integrity and financial due diligence to an external provider. To further develop the due diligence processes, CEPI would like to perform more of the integrity and financial due diligence and monitoring of our third parties in-house. To support this work, we are seeking to subscribe to a software screening tool.

For further information on the scope of the award, bidder qualification and instructions on hot to submit your proposal, please download our tender.

Deadline for submissions 3 November 2020. 

If you have any questions, please contact:

Cecilie Boye, Senior Risk and Compliance Manager

Email: [email protected]

In June 2020, the CEPI Board endorsed the Secretariat’s recommendation to develop an investment case and strategy for CEPI’s replenishment, to raise funds for the next CEPI strategy period, running from 2022-2026.

CEPI will not only seek to secure traditional public sector and philanthropic grant funding, which will be core to CEPI’s replenishment, but also build on the experience of financing vaccine development and manufacturing for COVAX through issuance of vaccine bonds via financing platforms such as the International Finance Facility for Immunisation (IFFIm), as well as explore ways to partner with multi-lateral development bank financing instruments.

It is envisaged that a series of preparatory and financing events in support of CEPI’s replenishment process will be organised in 2020 and 2021 to bring in this new funding.

In order to successfully develop and execute the replenishment strategy and related events, the Secretariat will occasionally require the services of a consultant / small consultancy team to be called upon throughout different stages of the replenishment process, for example to:

• Support the development and framing of the investment case that underpins CEPI’s new strategy (2022-2026)
• Support the design as well as assist with part of the execution of a series of preparatory events aimed at raising additional awareness of CEPI’s achievements and building support that will be solidified during a replenishment event in the third quarter of 2021
• Help CEPI cultivate support from Heads of State to draw in new investors and renew commitments from current investors

The expected duration for a contract awarded under this Request for Proposals is up to 31 Dec 2021.

Application details 

Please download our full tender for applicant requirements and details on how to apply.

The deadline for submission is midnight (23:59:59 GMT) on Wednesday 4 October 2020. Proposals received after the deadline will not be considered. All proposals should be sent electronically, in PDF format, to [email protected].

Questions

If you have any questions, please contact Leonie van Tongeren [email protected]

CEPI’s R&D team is responsible for the coordination of CEPI’s portfolio of vaccine candidates in preclinical and clinical stages of development, up to licensure and use in an outbreak situation. This team is also responsible for coordinating and funding critical elements to accelerate and ensure a rational decision making for the whole product development cycle of CEPI-supported vaccine candidates; from disease burden and diagnostics to immunological evaluation and preparations for field efficacy testing and processes to facilitate their future use in outbreaks and potential regulatory licensing.

To support this teams’ activities, along with the activities of the wider organisation, we are seeking the consultancy services from experts with experience in the following disciplines:

• CMC development, large scale manufacturing, facility due diligence, supply chain and tech transfer
• Regulatory Experts
• Infectious disease modellers

We are seeking to engage with individual consultants, consultants who are established within a partnership, or with consultancy firms who can provide and commit resources for the duration of a project (i.e. between 1 month to 3 years).

CEPI intends to implement framework agreements with successful applicants, to cover potential future provision of services as detailed in this request for proposals.

For further information on the scope of tender, including information on bidder qualification, tentative time plans and tender instructions please see our Request for Proposals below.

Deadline for submission of written proposals: 24 July 2020 (23:59:59 GMT)

Questions relating to this request for proposals should be directed to [email protected] and [email protected]

This Review is being commissioned by the CEPI Secretariat to assess the design, implementation and interim results of CEPI operations since its establishment in 2017. The Review aims to generate learnings about and assess the progress of CEPI’s Business Plan and targets, mid-way through the five-year period, as well as take into account suggestions to incorporate into the Strategic Plan for CEPI’s next five-year phase.

Please download the full tender and supporting documents below.

Deadline for submission is Midnight (23:59:59 GMT) on 20 December.

To prepare for advanced stage clinical trials investigating vaccine efficacy in the field, suitable epidemiological data is needed to support trial design and strengthen site and investigator capacity to conduct these trials.

CEPI is therefore providing grants for epidemiological studies that will contribute these data. These two-year prospective studies will be performed in five countries in West Africa (Nigeria, Benin, Sierra Leone, Liberia, and Guinea), with the primary objective of assessing incidence of symptomatic Lassa fever cases as well as incidence of Lassa virus infection as well as secondary objectives informing additional aspects of future phase 2b/3 clinical trials.

In CEPI’s role as the facilitator and funder for these epidemiology studies, CEPI now seeks to identify a qualified coordinating institution to support this large-scale, five-country programme from the planning and implementation phases through to close-out. This institution will develop and implement a coordination framework ensuring robust oversight, performance and capacity monitoring, and quality management of all activities across the five study countries for the duration of the Lassa epidemiology programme.

The identified institution will also facilitate the harmonized planning and analysis of study data, including the development of a programme statistical analysis plan and conduct of all programme-level analyses. Finally, the institution will provide support as needed in training curriculum development and provision, including harmonization of content and delivery across study consortia.

Please download the full tender below.

If you are considering submitting a proposal, please send an email to [email protected] by 6 January 2020.

CEPI is seeking consultancy services from experts with experience in strategy development, planning and prioritisation, decision making and project management, to support the organisation when in outbreak response mode.

Examples of tasks that may be requested include leading the planning cell of incident command, assisting in writing decision memos, and supporting the development of CEPI’s objectives and strategy based on lessons learnt in outbreak response activities.

Please download the full tender below.

Electronic copies of your proposals should be sent to [email protected] by 21 February 2020 in PDF format. 

CEPI is seeking external help to support its strategy development process for its next five year period (2022-2026) – termed CEPI 2.0. We anticipate that there will be a need for individual consultant(s) being seconded to CEPI for periods of time as part of the process. There will be need for both expertise in Strategy development processes and potentially project support resources.

Please download the full tender below.

Deadline for submission is Midnight (23:59:59 GMT) on 13 December. 

Please see below